podophyllotoxin has been researched along with nitrophenols in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelson, M; Bieghs, L; De Bruyne, E; Fostier, K; Jernberg-Wiklund, H; Johnsen, HE; Larsson, O; Lub, S; Maes, K; Menu, E; Nyegaard, M; Overgaard, MT; Schots, R; Van Valckenborgh, E; Vanderkerken, K | 1 |
1 other study(ies) available for podophyllotoxin and nitrophenols
Article | Year |
---|---|
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomimetic Materials; Biphenyl Compounds; Cell Line, Tumor; Drug Synergism; Humans; Mice; Mice, Inbred C57BL; Multiple Myeloma; Nitrophenols; Piperazines; Podophyllotoxin; Receptor, IGF Type 1; Sulfonamides | 2014 |